Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

81 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Next generation sequencing redefines a triple negative essential thrombocythaemia as double-positive with rare mutations on JAK2 V617 and MPL W515 hotspots.
Beucher A, Dib M, Orvain C, Bouvier A, Jouanneau-Courville R, Dobo I, Cottin L, Guardiola P, Rousselet MC, Blanchet O, Hunault M, Ugo V, Luque Paz D. Beucher A, et al. Among authors: guardiola p. Br J Haematol. 2019 Sep;186(5):785-788. doi: 10.1111/bjh.15954. Epub 2019 May 14. Br J Haematol. 2019. PMID: 31087331 Free article. No abstract available.
Concomitant CALR and LNK mutations leading to essential thrombocythemia with erythrocytosis.
Luque Paz D, Boyer F, Beucher A, Bouvier A, Jouanneau-Courville R, Guardiola P, Lambert D, Delneste Y, Hunault M, Blanchet O, Ugo V. Luque Paz D, et al. Among authors: guardiola p. Blood Cells Mol Dis. 2018 Jul;71:75-76. doi: 10.1016/j.bcmd.2018.04.002. Epub 2018 Apr 23. Blood Cells Mol Dis. 2018. PMID: 29703677 No abstract available.
Routine use of microarray-based gene expression profiling to identify patients with low cytogenetic risk acute myeloid leukemia: accurate results can be obtained even with suboptimal samples.
de la Blétière DR, Blanchet O, Cornillet-Lefèbvre P, Coutolleau A, Baranger L, Geneviève F, Luquet I, Hunault-Berger M, Beucher A, Schmidt-Tanguy A, Zandecki M, Delneste Y, Ifrah N, Guardiola P. de la Blétière DR, et al. Among authors: guardiola p. BMC Med Genomics. 2012 Jan 30;5:6. doi: 10.1186/1755-8794-5-6. BMC Med Genomics. 2012. PMID: 22289410 Free PMC article.
Daunorubicin and Its Active Metabolite Pharmacokinetic Profiles in Acute Myeloid Leukaemia Patients: A Pharmacokinetic Ancillary Study of the BIG-1 Trial.
Drevin G, Briet M, Bazzoli C, Gyan E, Schmidt A, Dombret H, Orvain C, Giltat A, Recher C, Ifrah N, Guardiola P, Hunault-Berger M, Abbara C. Drevin G, et al. Among authors: guardiola p. Pharmaceutics. 2022 Apr 5;14(4):792. doi: 10.3390/pharmaceutics14040792. Pharmaceutics. 2022. PMID: 35456626 Free PMC article.
Prognostic impact of day 15 blast clearance in risk-adapted remission induction chemotherapy for younger patients with acute myeloid leukemia: long-term results of the multicenter prospective LAM-2001 trial by the GOELAMS study group.
Bertoli S, Bories P, Béné MC, Daliphard S, Lioure B, Pigneux A, Vey N, Delaunay J, Leymarie V, Luquet I, Blanchet O, Cornillet-Lefebvre P, Hunault M, Bouscary D, Fegueux N, Guardiola P, Dreyfus F, Harousseau JL, Cahn JY, Ifrah N, Récher C; Groupe Ouest-Est d’Etude des Leucémies Aiguës et Autres Maladies du Sang (GOELAMS). Bertoli S, et al. Among authors: guardiola p. Haematologica. 2014 Jan;99(1):46-53. doi: 10.3324/haematol.2013.091819. Epub 2013 Aug 23. Haematologica. 2014. PMID: 23975179 Free PMC article. Clinical Trial.
Data-Mining Approach on Transcriptomics and Methylomics Placental Analysis Highlights Genes in Fetal Growth Restriction.
Chabrun F, Huetz N, Dieu X, Rousseau G, Bouzillé G, Chao de la Barca JM, Procaccio V, Lenaers G, Blanchet O, Legendre G, Mirebeau-Prunier D, Cuggia M, Guardiola P, Reynier P, Gascoin G. Chabrun F, et al. Among authors: guardiola p. Front Genet. 2020 Jan 9;10:1292. doi: 10.3389/fgene.2019.01292. eCollection 2019. Front Genet. 2020. PMID: 31998361 Free PMC article.
Different Impact of the Number of Organ Failures and Graft-Versus-Host Disease on the Outcome of Allogeneic Stem Cell Transplantation Recipients Requiring Intensive Care.
Orvain C, Beloncle F, Hamel JF, Thépot S, Mercier M, Kouatchet A, Farhi J, Francois S, Guardiola P, Asfar P, Hunault-Berger M, Mercat A, Ifrah N, Tanguy-Schmidt A. Orvain C, et al. Among authors: guardiola p. Transplantation. 2017 Feb;101(2):437-444. doi: 10.1097/TP.0000000000001143. Transplantation. 2017. PMID: 26950729
Prospective evaluation of gene mutations and minimal residual disease in patients with core binding factor acute myeloid leukemia.
Jourdan E, Boissel N, Chevret S, Delabesse E, Renneville A, Cornillet P, Blanchet O, Cayuela JM, Recher C, Raffoux E, Delaunay J, Pigneux A, Bulabois CE, Berthon C, Pautas C, Vey N, Lioure B, Thomas X, Luquet I, Terré C, Guardiola P, Béné MC, Preudhomme C, Ifrah N, Dombret H; French AML Intergroup. Jourdan E, et al. Among authors: guardiola p. Blood. 2013 Mar 21;121(12):2213-23. doi: 10.1182/blood-2012-10-462879. Epub 2013 Jan 15. Blood. 2013. PMID: 23321257 Free article. Clinical Trial.
81 results